Screening, development of transglutaminase-2 inhibitors and its derivative as anti-lung cancer agent by insilico and in vitro approaches.

Prachi P Parvatikar, Sumangala Patil, Joy Hoskeri, Sandeep Swargam, Raghvendra Kulkarni, Kusal K Das.

dc.contributor.author	Prachi P Parvatikar, Sumangala Patil, Joy Hoskeri, Sandeep Swargam, Raghvendra Kulkarni, Kusal K Das.
dc.date.accessioned	2021-07-01T07:39:28Z
dc.date.available	2021-07-01T07:39:28Z
dc.date.issued	2021
dc.identifier.citation	Prachi P Parvatikar, Sumangala Patil, Joy Hoskeri, Sandeep Swargam, Raghvendra Kulkarni, Kusal K Das. Screening, development of transglutaminase-2 inhibitors and its derivative as anti-lung cancer agent by insilico and in vitro approaches. Curr Computer Aided Drug Design. https://doi.org/10.2174/1573409917666210322120350. 2021.	en_US
dc.identifier.issn	15734099
dc.identifier.uri	http://hdl.handle.net/123456789/3797
dc.language.iso	en	en_US
dc.title	Screening, development of transglutaminase-2 inhibitors and its derivative as anti-lung cancer agent by insilico and in vitro approaches.	en_US
dc.type	Article	en_US